A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects
Clinical trial NCT04653467 · COMPLETED
Trial details
- NCT number
- NCT04653467
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-06
- Primary completion
- 2022-01-10
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.